Anson Funds Management’s Oragenics OGEN Stock Holding History

Anson Funds Management’s Portfolio OGEN Stock Details OGEN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q2	–	Sell	-1,656	Closed	-$1.74M	–	44
2019 Q1	$1.74M	Buy	+1,656	New	+$2.61M	1.21%	10

Other funds holding OGEN

Third Security Radford, Virginia $241M AUM 45.43% 1-Year Est. Return

HCS

Harvest Capital Strategies San Francisco, California $73.7M AUM 7.47% 1-Year Est. Return

Sabby Management Miami Beach, Florida $111M AUM 74.4% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

CVI Holdings Wilmington, Delaware $116M AUM 5.68% 1-Year Est. Return

Barclays London, United Kingdom $521B AUM 51.41% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Virtu Financial New York $3.18B AUM 65.92% 1-Year Est. Return

Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

Anson Funds Management's OGEN Position: Q2 2019 in Review

Anson Funds Management sold out of Oragenics (OGEN) in Q2 2019, closing a stake of 1,656 shares — an estimated $1.74M sold.

Anson Funds Management first reported a position in OGEN in Q1 2019 and held it in 1 quarter. The position peaked at $1.74M in Q1 2019. 15 funds tracked by Wall St. Rank hold OGEN as of Q2 2019.

Anson Funds Management reported no remaining Oragenics position as of Q2 2019 after selling out during the quarter.
Anson Funds Management sold 1,656 Oragenics shares in Q2 2019, an estimated $1.74M.
Anson Funds Management first reported a position in Oragenics in Q1 2019 and held it in 1 quarter.
Anson Funds Management's Oragenics position peaked at $1.74M in Q1 2019.
15 funds tracked by Wall St. Rank held Oragenics as of Q2 2019.

Based on Anson Funds Management's 13F filing for Q2 2019, filed 14 Aug 2019.